Canada · Delayed Price · Currency is CAD Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of CAD 38.26 million. The enterprise value is 56.87 million.
| Market Cap | 38.26M |
| Enterprise Value | 56.87M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Conavi Medical has 103.42 million shares outstanding. The number of shares has increased by 326.41% in one year.
| Current Share Class | 103.42M |
| Shares Outstanding | 103.42M |
| Shares Change (YoY) | +326.41% |
| Shares Change (QoQ) | -12.39% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 0.00% |
| Float | 68.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 54.20 |
| PB Ratio | -1.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.51 |
| EV / Sales | 80.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.75 |
Financial Position
The company has a current ratio of 0.60
| Current Ratio | 0.60 |
| Quick Ratio | 0.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.95 |
| Interest Coverage | -0.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -7,676.14% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.61% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -48.61% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 33.55 |
| Average Volume (20 Days) | 39,850 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of CAD 706,000 and -16.19 million in losses. Loss per share was -0.25.
| Revenue | 706,000 |
| Gross Profit | 759,000 |
| Operating Income | -20.27M |
| Pretax Income | -16.19M |
| Net Income | -16.19M |
| EBITDA | -19.80M |
| EBIT | -20.27M |
| Loss Per Share | -0.25 |
Balance Sheet
The company has 971,000 in cash and 19.57 million in debt, with a net cash position of -18.60 million or -0.18 per share.
| Cash & Cash Equivalents | 971,000 |
| Total Debt | 19.57M |
| Net Cash | -18.60M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | -20.75M |
| Book Value Per Share | -0.31 |
| Working Capital | -3.80M |
Cash Flow
In the last 12 months, operating cash flow was -20.62 million and capital expenditures -74,000, giving a free cash flow of -20.70 million.
| Operating Cash Flow | -20.62M |
| Capital Expenditures | -74,000 |
| Free Cash Flow | -20.70M |
| FCF Per Share | -0.20 |
Margins
| Gross Margin | 107.51% |
| Operating Margin | -2,870.40% |
| Pretax Margin | -2,292.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -326.41% |
| Shareholder Yield | -326.41% |
| Earnings Yield | -42.30% |
| FCF Yield | -54.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.04.
| Last Split Date | Oct 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |